Primary brain neoplasm
MONDO:0021632Also known as: primary brain neoplasm, primary brain tumor, primary brain tumour
1576 clinical trials for this condition and its sub-types, 87 tagged with Primary brain neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Primary brain neoplasm
-
Brain astrocytoma 2 trials · 5 incl. sub-types
4 sub-types
- Cerebellar astrocytoma 2 trials Sub-types →
- Diencephalic astrocytomas 0 trials · 1 incl. sub-types Sub-types →
- Brain stem astrocytic neoplasm 0 trials Sub-types →
- Cerebral astrocytoma 0 trials Sub-types →
Most studied deeper sub-types
-
Experimental antibody APX005M takes on childhood brain cancers
Disease control CompletedThis early-stage trial is testing an experimental drug called APX005M in 32 children with brain tumors that have come back or are hard to treat, including a type of brain stem glioma. The drug works by activating the immune system to attack cancer cells. The main goals are to fin…
Phase 1 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Chemotherapy delivered straight to the brain: a new hope for recurrent tumors?
Disease control CompletedThis early-phase study tested a method called convection-enhanced delivery to pump the chemotherapy drug topotecan directly into brain tumors in 16 patients with recurrent malignant brain tumors. The goal was to see if this approach is safe and to find the best dose, while also m…
Phase 1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug targets tough childhood cancers with genetic flaws
Disease control CompletedThis phase 2 trial tested the drug samotolisib in 18 children and young adults with advanced solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that had spread, returned, or stopped responding to treatment. Only patients whose tumors had specific mutations in the TSC or…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden brain tumors
Disease control CompletedThis completed Phase 1 trial tested whether a dye called indocyanine green (ICG) can make brain tumor cells glow during surgery, helping surgeons see and remove them more completely. 363 adults with brain tumors received an ICG injection before surgery, and special cameras captur…
Phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Glowing dye could help surgeons spot hidden brain tumor cells
Diagnosis CompletedThis study tests whether a fluorescent dye called tozuleristide, given before surgery, can make brain tumor tissue glow under a special imaging system. Surgeons can then see and remove more of the tumor while sparing healthy brain. The trial enrolls adults with certain types of b…
Phase 2 • Sponsor: John Yu • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
New Sugar-Based tracer could spot brain tumors on SPECT scans
Diagnosis CompletedThis study tested a radioactive sugar-like tracer called 99mTc-1-thio-D-glucose to see if it can make brain tumors visible on SPECT scans. Sixteen adults with primary or recurrent brain tumors received one injection, then had scans at several time points. Researchers measured how…
Phase 1/2 • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
New contrast agent shows promise for brain tumor MRI scans
Diagnosis CompletedThis completed Phase 3 trial tested whether Elucirem (gadopiclenol) provides better MRI images of brain gliomas compared to the standard contrast agent Dotarem. 138 adults with primary or recurrent brain tumors received one of the two agents during DSC-MRI perfusion scans. The ma…
Phase 3 • Sponsor: Guerbet • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
New Gadolinium-Free MRI dye shows promise for brain scans
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, made with manganese instead of gadolinium, in 18 adults with known brain lesions (like tumors or multiple sclerosis). The goal was to see if it is safe and can detect lesions as well as current gadolinium-based dyes. Each…
Phase 2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Brain games for young cancer survivors: a promising pilot study
Symptom relief CompletedThis study tested whether a computer-based cognitive training program could help children with brain tumors who had radiation therapy. 45 children were randomly assigned to either an adaptive or non-adaptive training program. The goal was to see if the training could improve thin…
Sponsor: Children's Oncology Group • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Can a VR headset calm brain tumor Patients' anxiety?
Symptom relief CompletedThis study tested whether using a virtual reality (VR) headset at home could help reduce anxiety and distress in adults with primary brain tumors. Sixty-one participants used the VR headset for 4 weeks and filled out symptom questionnaires. The goal was to see if this approach is…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New tool aims to ease burden on brain cancer caregivers
Symptom relief CompletedThis study tested whether a web-based tool called eSNAP, combined with a caregiver navigator, could help family caregivers of brain cancer patients feel less anxious and burdened. The tool helps caregivers map out their support network, while the navigator provides guidance. Rese…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Brain tumor patients get help for 'Chemo Brain' with new telehealth program
Symptom relief CompletedThis pilot study tested a telehealth program called C-SMART for people with primary brain tumors who have mild memory or thinking problems. The program combines cognitive rehabilitation with mindfulness training over 8 weekly sessions. Researchers enrolled 32 patients and caregiv…
Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Brain tumor insomnia targeted by CBT in new pilot study
Symptom relief CompletedThis study tested a type of talk therapy called Cognitive Behavioral Therapy for Insomnia (CBT-I) in 70 people with brain tumors who also had trouble sleeping. The therapy involved six weekly group sessions delivered online. The main goal was to see if the approach was practical …
Phase 2 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Childhood brain tumor survivors face hidden hormone risks years later
Knowledge-focused CompletedThis study looks at long-term hormone and metabolic problems in people who survived a childhood brain tumor. Researchers will check survivors for issues like growth, thyroid, and blood sugar problems, and see how these relate to the tumor and its treatment. The goal is to help do…
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New program aims to better involve relatives in brain injury care
Knowledge-focused CompletedThis study developed and tested a program to help nurses better support relatives of patients with acquired brain injury or malignant brain tumors. The program included nurse training, a dialog tool, a peer support list, videos, and documentation guidelines. Researchers tested it…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Brain tumor patients and caregivers speak out: what they really need
Knowledge-focused CompletedThis completed study from Mayo Clinic interviewed 33 adults with brain or central nervous system (CNS) tumors, along with their caregivers, to learn about their biggest challenges and needs. The goal was to identify areas where doctors and healthcare teams can offer better suppor…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Childhood brain tumor survivors face hidden hormone risks
Knowledge-focused CompletedThis study examined 12 childhood brain tumor survivors to understand long-term hormone and metabolic problems. Researchers checked for issues like growth hormone deficiency, thyroid problems, obesity, and abnormal cholesterol. The goal is to help doctors better monitor and manage…
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC